Showing results (311-320 of 320) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 320 results.
Life Sciences|September 25, 2002
Study of brain uptake and biodistribution of [11C]toluene in non-human primates and miceM R Gerasimov, R A Ferrieri, W K Schiffer, et al.
Redox Biology|February 25, 2014
Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injuryMaria Entezari, Mohammad Javdan, Daniel J Antoine, et al.
Cancer Research|October 3, 2008
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2Chun-ling Dai, Amit K Tiwari, Chung-Pu Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 14, 2006
WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activityKaren L Marquis, Annmarie L Sabb, Sheree F Logue, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 1, 2022
Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort StudyDamien R Ashby, Ben Caplin, Richard W Corbett, et al.
The American Journal of Clinical Nutrition|April 25, 2014
Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to foodAnthony P Goldstone, Christina G Prechtl, Samantha Scholtz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 29, 2022
Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort studyDamien R Ashby, Ben Caplin, Richard W Corbett, et al.
Journal of Medicinal Chemistry|November 7, 2009
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Luca Arista, Giorgio Bonanomi, et al.
Journal of Medicinal Chemistry|October 31, 2003
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonistGregor J Macdonald, Clive L Branch, Michael S Hadley, et al.
Journal of Medicinal Chemistry|September 18, 2007
1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Giorgio Bonanomi, Frank E Blaney, et al.
Pageof 32